IRIS Accounts Production v25.1.3.33 15495838 Board of Directors 16.2.24 28.2.25 28.2.25 false true false false true false 29630 29630 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh154958382024-02-15154958382025-02-28154958382024-02-162025-02-28154958382024-02-1515495838ns15:EnglandWales2024-02-162025-02-2815495838ns14:PoundSterling2024-02-162025-02-2815495838ns10:Director12024-02-162025-02-2815495838ns10:PrivateLimitedCompanyLtd2024-02-162025-02-2815495838ns10:SmallEntities2024-02-162025-02-2815495838ns10:AuditExempt-NoAccountantsReport2024-02-162025-02-2815495838ns10:SmallCompaniesRegimeForDirectorsReport2024-02-162025-02-2815495838ns10:SmallCompaniesRegimeForAccounts2024-02-162025-02-2815495838ns10:FullAccounts2024-02-162025-02-2815495838ns10:Director2422024-02-162025-02-2815495838ns10:Director2422025-02-2815495838ns10:Director22024-02-162025-02-2815495838ns10:CompanySecretary12024-02-162025-02-2815495838ns10:RegisteredOffice2024-02-162025-02-2815495838ns5:CurrentFinancialInstruments2025-02-2815495838ns5:ShareCapital2025-02-2815495838ns5:RetainedEarningsAccumulatedLosses2025-02-2815495838ns5:PlantMachinery2024-02-162025-02-2815495838ns5:PlantMachinery2025-02-2815495838ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-28154958381ns10:Director12024-02-15154958381ns10:Director12024-02-162025-02-28154958381ns10:Director12025-02-28
REGISTERED NUMBER: 15495838 (England and Wales)















Unaudited Financial Statements

for the Period

16 February 2024 to 28 February 2025

for

JM Clinical Research Ltd

JM Clinical Research Ltd (Registered number: 15495838)






Contents of the Financial Statements
for the Period 16 February 2024 to 28 February 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


JM Clinical Research Ltd

Company Information
for the Period 16 February 2024 to 28 February 2025







DIRECTORS: Dr J A McColm
P J McColm





SECRETARY: Mrs C Bourton-Williams





REGISTERED OFFICE: 1st Floor Offices
10 Hereford Road
Abergavenny
Monmouthshire
NP7 5PR





REGISTERED NUMBER: 15495838 (England and Wales)





ACCOUNTANTS: Ashmole & Co
Park Chambers
10 Hereford Road
Abergavenny
Monmouthshire
NP7 5PR

JM Clinical Research Ltd (Registered number: 15495838)

Balance Sheet
28 February 2025

Notes £    £   
FIXED ASSETS
Tangible assets 4 410

CURRENT ASSETS
Debtors 5 3,250
Cash at bank 50,901
54,151
CREDITORS
Amounts falling due within one year 6 43,147
NET CURRENT ASSETS 11,004
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,414

PROVISIONS FOR LIABILITIES 5
NET ASSETS 11,409

CAPITAL AND RESERVES
Called up share capital 2
Retained earnings 11,407
11,409

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JM Clinical Research Ltd (Registered number: 15495838)

Balance Sheet - continued
28 February 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 April 2025 and were signed on its behalf by:





Dr J A McColm - Director


JM Clinical Research Ltd (Registered number: 15495838)

Notes to the Financial Statements
for the Period 16 February 2024 to 28 February 2025

1. STATUTORY INFORMATION

JM Clinical Research Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - at variable rates on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

JM Clinical Research Ltd (Registered number: 15495838)

Notes to the Financial Statements - continued
for the Period 16 February 2024 to 28 February 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 500
At 28 February 2025 500
DEPRECIATION
Charge for period 90
At 28 February 2025 90
NET BOOK VALUE
At 28 February 2025 410

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 3,250

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 12,617
Other creditors 30,530
43,147

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 28 February 2025:

£   
Dr J A McColm and P J McColm
Balance outstanding at start of period -
Amounts repaid (29,630 )
Amounts written off -
Amounts waived -
Balance outstanding at end of period (29,630 )